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Human noroviruses are the predominant cause of food-
borne gastroenteritis worldwide. Strains of norovirus also 
exist that are uniquely associated with animals; their con-
tribution to the incidence of human illness remains unclear. 
We tested animal fecal samples and identiﬁ  ed GIII (bovine), 
GII.18 (swine), and GII.4 (human) norovirus sequences, 
demonstrating for the ﬁ   rst time, to our knowledge, that 
GII.4-like strains can be present in livestock. In addition, we 
detected GII.4-like noroviral RNA from a retail meat sample. 
This ﬁ  nding highlights a possible route for indirect zoonotic 
transmission of noroviruses through the food chain.
N
oroviruses (NoVs) are a widespread cause of nonbac-
terial gastroenteritis (1,2). These agents are highly 
infectious, and person-to-person contact, fomites, and 
food have all been implicated in their spread (3). NoVs in-
fect hosts of all ages and can cause very large outbreaks 
in closed settings. For example, observations from cruise 
ships demonstrate that infection has spread rapidly (4).
Since the Norovirus genus comprises viruses that in-
fect humans, pigs, cattle, and mice, the possibility for zoo-
notic transmission of infection exists. In general, zoonotic 
transfer could occur either indirectly through the food chain 
or directly through animal contact. Transfer of animal virus 
to humans may produce an infection more serious than that 
traditionally associated with NoV (5). High-proﬁ  le exam-
ples of zoonotic viruses transmitted to humans include the 
highly pathogenic avian inﬂ  uenza virus, known as H5N1 
(6), and the severe acute respiratory syndrome (SARS) 
coronavirus (7). If NoVs have the potential for zoonotic 
transmission, monitoring emerging viral strains and track-
ing their virulence characteristics will be important to limit 
the potential for negative public health effects from any 
zoonotic transfer event.
NoVs are nonenveloped, polyadenylated, single-
stranded, positive-sense RNA viruses of the family Cali-
civiridae (8). The noroviral genome is 7.3–7.7 kb in length 
and contains 3 open reading frames (ORFs) (9). ORF1 en-
codes a polyprotein that is autocatalytically cleaved to pro-
duce an N terminal protein, the nucleoside triphosphatase, 
a 3A-like protein, the viral VpG, a 3C-like protease, and the 
RNA-dependent RNA-polymerase (10,11). ORF2 encodes 
the major capsid protein (12), and ORF3 codes for a mi-
nor structural protein (13). NoV strains are currently clas-
siﬁ  ed according to alignment of the amino acid sequence 
for the major capsid protein. This classiﬁ  cation system di-
vides the known NoV into 5 genogroups (14). Within these 
genogroups, 31 genetic clusters have been deﬁ  ned (14,15). 
Genogroup GI, GII, and GIV viruses infect humans; GIII 
NoV infect cattle; and GV NoVs infect mice (16,17). To 
date, NoVs detected in naturally infected pigs belong to GII 
(15,18). The porcine and human viruses belong to different 
clusters within GII; porcine viruses are identiﬁ  ed as GII.11, 
GII.18, and GII.19, and the human viruses make up the re-
maining 16 GII clusters (15,18).
Porcine NoV detected in Japan, the Netherlands, and 
the United States is closely related to the human NoV 
(15,18,19). Furthermore, human NoV can replicate and in-
duce an immune response in gnotobiotic pigs (20), which 
indicates that swine could serve as a reservoir for human 
NoV. In addition, the genetic similarity between human 
and swine NoV strains raises the possibility that porcine-
human recombinants could emerge during co-infection of 
the same host (15).
Cattle can also be infected with NoV; however, this 
strain is less closely related to the human NoV (21). Bovine 
NoVs produce recombinants in a similar manner as human 
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NoVs (22). Thus, a cow co-infected with both bovine and 
human strains of NoV could conceivably produce a recom-
binant virus with altered virulence properties.
In this study, we tested fecal samples obtained from pig 
and dairy farms, as well as retail meat samples for the NoV 
genome. Swine (GII.18) and bovine (GIII) strains were 
detected in the swine and cattle samples, respectively. We 
also identiﬁ  ed GII.4 (human) NoV sequences in both types 
of animal sample. This is the ﬁ  rst report, to our knowledge, 
of GII.4-like NoV in animal fecal samples. Additionally, 
we found a GII.4-like strain of NoV associated with a retail 
raw pork sample.
These data suggest a potential mechanism for zoonotic 
transmission of NoV to humans through meat, dairy, or 
farm samples from infected pigs and cows. These ﬁ  ndings 
also highlight the possibility that a recombinant swine/hu-
man or bovine/human NoV could emerge with altered tro-
pism or virulence characteristics.
Materials and Methods
Swine fecal samples (N = 120) were collected in 3 sets 
from 10 farms in Canada farms. In September and Octo-
ber 2005, 4 composite samples were collected from each 
farm: 3 of fresh pen manure and 1 of stored pit manure. 
This sampling program was repeated in November and 
December of 2005 and again in April and May 2006. The 
fecal samples were placed into sterile containers, shipped 
overnight on ice, and stored frozen. Bovine fecal samples 
(N = 179) were collected from May to October 2006 from 
45 different dairy farms in Canada. In this sampling pro-
gram, farms were sampled only once each; 4 composite 
samples were taken at each farm, 1 each from calf pens 
(fresh), milking cow pens (fresh), heifer pens (fresh), and 
storage pits (stored). The dairy cattle samples were also 
placed into sterile containers, shipped overnight on ice, and 
stored frozen. A total of 156 retail meat samples were pur-
chased, 15 at a time, during January–March 2006, and 6 
at a time during July–November 2006. The last purchase 
consisted of only 4 samples. Each purchase was equally 
divided between samples of raw chicken, beef, and pork, 
except for the last, which had 1 extra chicken sample.
Fecal samples were suspended in 0.9% NaCl (5% wt/
vol), vortexed brieﬂ  y, and clariﬁ  ed through a combination 
glass ﬁ  ber/PVDF 0.22-μm ﬁ  lter (Millipore, Mississauga, 
Ontario, Canada). RNA was extracted from a 140-μL sam-
ple of the resulting ﬁ  ltrate by using the QIAamp viral RNA 
extraction kit according to the manufacturer’s recommen-
dations (QIAGEN, Mississauga, Ontario, Canada). Total 
RNA was extracted from 25-g meat samples by using Tri 
reagent (Sigma, Oakville, Ontario, Canada) and Dynabeads 
coated with oligo-dT (Invitrogen, Burlington, Ontario, 
Canada) as described (23).
The RNA was used as a template for 1-step reverse-
transcription–PCR (RT-PCR) using Monroe region 
B primers (24) or Ando region A primers (25) and the 
OneStep RT-PCR kit (QIAGEN). Amplicons of 213 bp 
and 123 bp were considered to be presumptively positive 
for region B and region A, respectively. They were gel 
puriﬁ  ed by using a QIAquick gel extraction kit (QIA-
GEN) and sequenced on both strands by DNA Landmarks 
(St. Jean sur Richelieu, Québec, Canada). The primer 
sequences were removed, and the resulting 172 bp or 
81 bp of sequence was aligned to NoV standard geno-
types (G1.1 GenBank accession no. M87661, GI.2 no. 
L07418, GI.3 no. U04469, GI.4 no. AB042808, GI.6 no. 
AF093797, GII.1 no. U07611, GII.2 no. X81879, GII.3 
no. U02030, GII.4 nos. X86557 and AY502023, GII.5 no. 
AF397156, GII.6 no. AB039776, GII.8 no. AB039780, 
GII.9 no. AY038599, GII.10 no. AF504671, GII.11 no. 
AB074893, GII.12 no. AB045603, GII.16 no. AY772730, 
GII.17 no. AY502009, GII.18 no. AY823305, G3.1 no. 
AJ011099, G3.2 no. AF097917, G4.1 no. AF414426, 
G5.1 no. AY228235 [14,15]) using ClustalW (26). The 
alignments were subjected to phylogenetic analysis with 
2,000 replicates for bootstrapping by using the Seqboot, 
Dnadist (F84), Neighbor, and Consense programs, as 
implemented in the PHYLIP package (27). Phylogenetic 
trees were generated by using TreeView software (28).
Results and Discussion
NoV Detection in Swine Fecal Samples
A total of 120 swine fecal samples were tested for NoV 
RNA by using region B primers (24); of these, 30 were 
conﬁ  rmed by sequence analysis to contain partial genomic 
sequence from NoV. Detecting NoV RNA from 25% of 
swine fecal samples tested in this study contrasts with the 
results of other surveys, in which the rates observed were 
2% in US adult swine (15), 20% in US ﬁ  nisher pigs (older, 
heavier pigs being ﬁ  nished before slaughter) (29), and 0% 
in Venezuelan pigs (30). The different speciﬁ  cities of the 
primer sets used in the 4 studies likely account for the dif-
ferences in virus recovery.
The sequence of the NoV polymerase region ampliﬁ  ed 
was determined for the 30 strains and compared with those 
of reference strains. According to the region B sequence 
analysis, 3 different genotypes of NoV were detected in the 
Canadian pig samples (Figure 1), belonging to the swine 
GII.11 cluster (18), the swine GII.18 cluster (15), and the 
human GII.4 (Farmington Hills) cluster (14) (Figure 1). 
There were 22 strains of the swine GII.18 type, 6 of the 
swine GII.11 type, and 4 of the human GII.4 type; 2 sam-
ples contained both a swine GII.11 and a swine GII.18 vi-
rus. Sequences on both strands for the entire 172-bp region RESEARCH
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were obtained for 11 swine GII.18 viruses, 1 swine GII.11 
virus, and 4 human GII.4 viruses. The 11 swine GII.18 
strains had pairwise nucleotide identities ranging from 82% 
to 99% with no 2 identical strains (data not shown). Se-
quences from 2 of the 4 detected human strains were iden-
tical to each other and to the Farmington Hills reference 
strain (CE-M-05–0045 and CE-M-05–0102, Figure 2). 
The other 2 human NoV sequences ampliﬁ  ed from swine 
manure were not identical to any other known sequences 
(CE-M-06–0013 and CE-M-05–0114, Figure 2). None 
of the amplicons sequenced were identical to the labora-
tory strains that we routinely use in our research activities 
(BMH-06–001 and BCCDC-04–684, Figure 2). Reasons 
for the incomplete sequencing of the remaining strains in-
clude low concentrations of RNA and overlapping peaks in 
portions of the chromatograms. A single representative of 
each group is shown in Figure 1 for clarity.
These results raise 2 possible issues related to public 
health. The ﬁ  rst is that GII.4 NoV may be transferred di-
rectly from pigs to humans or from humans to pigs, pro-
viding a zoonotic source for human NoV outbreaks and a 
human source for pig NoV outbreaks. Second, pigs may 
be co-infected with both a human and a swine strain of 
NoV, potentially leading to recombination and generation 
of a new NoV strain with altered virulence properties. We 
did not identify GII.18-like and GII.4-like NoVs from the 
same manure sample; however, on 3 separate occasions, 
we detected both a GII.4-like and a GII.18-like NoV from 
the same farm on the same sampling date. A new variant 
of NoV with increased virulence has been seen in the GII.4 
cluster in the past (31,32).
NoV Detection in Bovine Fecal Samples
Of the 179 bovine fecal samples tested for NoV RNA 
with region B primers (24), 3 were conﬁ  rmed by sequence 
analysis to contain NoV genomes. Thus, we detected NoV 
RNA in 1.6% of bovine fecal samples tested in this study, 
in contrast to other surveys, in which the rates were 72% 
of US veal calves (33) and 4% of Dutch dairy cattle speci-
mens (34). This ﬁ  nding likely reﬂ  ects the speciﬁ  city of the 
primer sets used, although it may also relate to the type of 
animal tested.
The sequence for region B of the NoV polymerase was 
determined for these NoV strains and compared with refer-
ence strains. Based on this sequence, 2 different genotypes 
of NoV were detected in the Canadian dairy farm samples, 
belonging to the bovine GIII.2 Newbury cluster and to the 
human GII.4 Farmington Hills cluster. The complete 172-
bp region B sequence was conﬁ  rmed only for the sequence 
from CE-M-06–0509; this sequence was not identical to 
any of the other detected GII.4 sequences (Figure 2).
We also obtained an amplicon representing region A 
of the NoV polymerase from CE-M-06–0509. By region B 
phylogeny, the strain was classiﬁ  ed as GII.4 (Farmington 
Hills) NoV (CE-M-06–0509; Figures 1, 2). Interestingly, 
the region A sequence did not share >77% identity with 
any of the NoV strains in the GenBank database. Phy-
logenetic comparisons to the standard viruses described 
by Zheng et al. (14) were not successful in assigning a 
genogroup and cluster for this sequence; bootstrap values 
were 16%–40% for most branches in the tree (data not 
shown). A large grouping of strains did emerge in this 
analysis, showing that in region A, this NoV strain was 
more closely related to GII.1, GII.2, GII.3, GII.4, GII.5, 
GII.10, GII.12, and GIII.1 sequences than to the other 
reference strains (data not shown). This ﬁ  nding indicates 
that the viruses detected and characterized as GII.4 NoV 
by using region B primers from swine and bovine ma-
nure (Figures 1 and 2) may represent novel NoV types, 
with genetic content slightly different from the previously 
recognized human, swine, and bovine-type species. This 
ﬁ  nding would also explain the difﬁ  culty we have had in 
obtaining region A, C, and D amplicons from the other 
manure samples (data not shown).
Human NoVs have not been shown experimentally to 
infect cattle; however, the human and bovine NoVs share 
a cross-reactive epitope in their capsid proteins (35). The 
risk for bovine NoV infection in humans is thought to be 
low (21). Co-infection of an animal with both human and 
bovine NoV may result in a recombinant agent with altered 
virulence, as the bovine NoVs have been shown to undergo 
Figure 1. Unrooted neighbor-joining phylogenetic tree of 
representative noroviral strains and reference strains based on 
172 bp of the RNA-dependent RNA polymerase region. GenBank 
accession nos. are indicated for the 5 reference strains (plain 
type), and the C-EnterNet sample codes are indicated for the 
representative strains identiﬁ   ed in this study (boldface type). 
Bootstrap values are shown as percentages along the central 
branchesHuman Noroviruses in Swine and Cattle
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extensive genetic recombination in a similar manner to the 
human viruses (36–39).
NoV Detection in Retail Raw Meat Samples
To date, 156 retail meat samples have been processed 
and tested for the presence of NoV. One sample of raw 
pork has tested positive for a NoV of the GII.4 cluster (CE-
R1–06–0027; Figures 1, 2). The region B sequence for this 
strain was not identical to any of the other sequences iden-
tiﬁ  ed in this study (Figure 2). While we cannot determine 
the source of the contamination (i.e., at slaughter, during 
handling, or during packaging), our ﬁ  ndings demonstrate 
that retail meat is a potential route for the indirect zoonotic 
transmission of NoV. This ﬁ  nding highlights the impor-
tance of proper handling and cooking for meat products. 
NoV titer is reduced by 4 orders of magnitude in <1 min 
at 71°C (40), the temperature which Health Canada recom-
mends for the cooking of pork chops.
Conclusion
This is the ﬁ  rst report, to our knowledge, of GII.4-like 
NoV sequences in animal fecal samples. The GII.4 NoV 
sequences were all detected in fresh manure samples taken 
from animal pens, which limits the chances that they were 
derived from an unknown source of human waste. They 
were sampled from different farms on different days, and 
results from all processing and PCR control samples were 
negative. The use of the human-speciﬁ  c region B primer set 
(24) in our study allowed the identiﬁ  cation of human NoV 
from animal specimens, in contrast to previous surveys,in 
which swine or bovine-speciﬁ  c RT-PCR primers were used 
(15,18,19,34).
Although GII.4 viruses can infect piglets experimen-
tally (20), these data are the ﬁ  rst indication that such infec-
tions may occur naturally as well. We have also identiﬁ  ed 
partial GII.4 NoV genomic sequences for the ﬁ  rst time in 
cattle feces. Retail samples have not been previously tested 
as part of a surveillance scheme for the presence of NoV. 
Our ﬁ  ndings support previous suggestions that NoV may 
have a zoonotic route of transmission to humans (15). It 
follows that infected humans may pass the virus to live-
stock as well, and some outbreaks of gastroenteritis in farm 
animals may be prevented by controlling the access of ill 
workers to livestock. Our results also highlight the possibil-
ity that a recombinant swine/human or bovine/human NoV 
could emerge with altered tropism or virulence characteris-
tics. In conclusion, we stress the importance of monitoring 
existing and emerging NoV strains to mitigate the potential 
impact of a recombinant NoV’s being transmitted to the hu-
man population from either a swine or a bovine source.
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